cannabis.wine / intel

Maryland

Last updated July 7, 2026 AI-drafted — pending review

Maryland operates one of the most restrictive intoxicating hemp regimes in the country. Under Alcoholic Beverages and Cannabis Article §36-1102 (2023), it is unlawful for anyone without a Maryland Cannabis Administration (MCA) license to distribute a product intended for human consumption or inhalation that contains more than 0.5 mg of THC per serving or 2.5 mg of THC per package. Enforcement is handled by the Alcohol, Tobacco, and Cannabis Commission (ATCC), which received significantly expanded seize-on-sight authority under SB 214/HB 12 (2025) — the 'THC Labeling Law.' The Maryland Court of Special Appeals upheld these restrictions in September 2025, closing off pre-enforcement challenges. Nearly all hemp-derived Delta-9 beverages sold nationally exceed Maryland's caps and cannot legally be sold outside licensed cannabis dispensaries. Beverages are additionally captured by SB 215 (2025), which removed a cannabinoid-beverage sales tax exemption. HB 1523 (2026, Alcoholic Beverages Modernization Act) and SB 820 (2026, ATCC unauthorized consumable products enforcement) remain in play but do not loosen the mg caps. Maryland is effectively closed to any hemp beverage brand not licensed as a Maryland cannabis operator, and the ATCC is actively conducting seizures and civil enforcement.

Status
Blocked
DTC shipping
Highly restricted — DTC shipment of hemp Delta-9 products exceeding 0.5mg/serving or 2.5mg/package to Maryland addresses violates ABCA §36-1102 and subjects sender and product to ATCC seizure and civil penalty; compliant products (at or below the mg caps) permitted; medical cannabis delivery permitted through MCA-licensed dispensaries and delivery services (extended to July 1, 2026 by SB 215)
Serving cap
0.5 mg THC per serving for products intended for human consumption or inhalation, for anyone without a Maryland Cannabis Administration cannabis license (ABCA §36-1102)
Container cap
2.5 mg THC per package for products intended for human consumption or inhalation, for anyone without a Maryland Cannabis Administration cannabis license (ABCA §36-1102); packaging must comply with ABCA §36-203.1 and COMAR 14.17.18
Age gate
21+ for any intoxicating THC product (COMAR 14.17.18); adult-use cannabis 21+; medical cannabis 18+ (or minors with qualifying condition and parental consent)
License
MCA cannabis license required for any distribution of THC products exceeding 0.5mg/serving or 2.5mg/package; USDA hemp producer license for cultivation; MDA hemp registration; no separate hemp beverage retail license (any beverage over the mg caps must go through MCA-licensed dispensaries)
Regulator
Maryland Alcohol, Tobacco, and Cannabis Commission (ATCC) — enforcement of intoxicating THC products outside the licensed cannabis market; seize-on-sight authority under ABCA §36-203.1 and COMAR 14.17.18 (SB 214/HB 12, 2025); Maryland Cannabis Administration (MCA) — licensing of dispensaries and cannabis operators under Alcoholic Beverages and Cannabis Article Title 36; Maryland Department of Agriculture — hemp cultivation via USDA program
Current rule effective
July 1, 2023
Next known change — in 117 days
November 12, 2026 — Federal P.L. 119-37 § 781 takes effect. Maryland's 0.5mg/serving and 2.5mg/package caps for non-cannabis-licensed sellers are already tighter than Section 781's incoming 0.4mg/container federal ceiling. Section 781 will actually align the two frameworks more closely, but Maryland's requirement that anything over the mg caps be sold only through MCA-licensed dispensaries will remain the operative barrier. Federal preemption arguments are unlikely to change Maryland's channel restriction, since MCA licensure is the primary compliance path.
Federal alignment (P.L. 119-37 § 781)
Aligned with federal Maryland's 0.5mg/serving and 2.5mg/package caps are among the tightest in the country and were designed to route intoxicating THC into the licensed cannabis channel. Section 781's incoming 0.4mg per-container federal ceiling is slightly tighter than Maryland's 2.5mg per-package cap, but the operative barrier for hemp beverage brands in Maryland is not potency alone — it is the MCA-licensure requirement for anything above the mg caps. Section 781 does not disturb Maryland's channel restriction, and hemp beverage brands not licensed as Maryland cannabis operators will remain unable to reach general retail post-cliff.

Retail channels

  • MCA-licensed adult-use cannabis dispensaries: cannabis-derived Delta-9 products at any potency; 21+ required
  • MCA-licensed medical cannabis dispensaries: patient-only access to full-potency products
  • General retail (grocery, convenience, wellness, CBD stores): compliant hemp-derived Delta-9 products at or below 0.5mg/serving and 2.5mg/package only
  • Hemp beverages exceeding the mg caps: PROHIBITED outside MCA dispensaries; ATCC enforcement active
  • Non-intoxicating hemp CBD, CBG products: permitted at general retail
  • Delta-8, delta-10, HHC, THC-O, THCA products exceeding mg caps: PROHIBITED; ATCC seize-on-sight authority
  • On-site consumption establishments (MCA-licensed): outdoor smoking, vaping, consumption permitted with local approval
  • Online DTC of non-compliant hemp beverages to Maryland: PROHIBITED and actively enforced

Statutes & bills cited

  • Md. Code, Alcoholic Beverages and Cannabis Article §36-1102 — prohibits distribution of products intended for human consumption or inhalation containing >0.5 mg THC per serving or >2.5 mg per package without an MCA cannabis license (effective July 1, 2023)
  • Md. Code, Alcoholic Beverages and Cannabis Article §36-203.1 — THC product packaging, labeling, and safe-packaging standards; codified via COMAR 14.17.18
  • SB 214/HB 12 (2025) — THC Labeling Law; strengthened ATCC seize-on-sight enforcement authority for non-compliant intoxicating THC products
  • SB 215 (2025) — extended medical cannabis dispensary delivery through July 1, 2026; removed a certain food-sales-tax exemption for cannabinoid beverages
  • COMAR 14.17 — MCA regulatory chapter (dispensaries, licensing, product standards)
  • COMAR 14.17.18 — THC product packaging and labeling standards
  • HB 1523 (2026) — introduced Feb 13, 2026; alcohol regulatory framework amendments (did not alter mg caps); 2026 session ended April 13, 2026
  • SB 820 (2026) — ATCC enforcement and seizure authority for unauthorized consumable products
  • HB 1519 (2026) — Cannabis Reform and Opportunity Act; alterations to management service agreements, advertising, and penalties
  • Maryland Court of Special Appeals ruling (September 2025) — upheld mg caps and 21+ requirements against industry challenge

Maryland runs one of the country’s tightest state-level frameworks on intoxicating hemp, and it is effectively closed to hemp beverage brands that are not licensed as Maryland cannabis operators. The operative rule sits in the Alcoholic Beverages and Cannabis Article §36-1102, which makes it unlawful for anyone without a Maryland Cannabis Administration (MCA) license to distribute a product intended for human consumption or inhalation that contains more than 0.5 mg of THC per serving or 2.5 mg of THC per package. The mg caps apply to hemp-derived and marijuana-derived THC alike, and they apply regardless of whether the product is sold at retail, shipped DTC, or given away in a promotional context. Because virtually every hemp-derived Delta-9 beverage on the national market contains 2.5mg to 10mg per can — well above the 2.5mg per-package cap — the practical effect is that hemp beverages must either be sold through an MCA-licensed cannabis dispensary or not sold in Maryland at all. Enforcement runs through the Alcohol, Tobacco, and Cannabis Commission (ATCC), which received substantially expanded seize-on-sight authority under SB 214/HB 12 (2025), commonly called the ‘THC Labeling Law.’ ATCC’s authority is codified in ABCA §36-203.1 and COMAR 14.17.18, which govern packaging, labeling, and safe-packaging standards. ATCC has stated publicly (May 2026 briefings to the Senate Finance Committee) that it uses packaging and product display as prima facie evidence of a violation, may seize products on sight, and pursues civil convictions carrying $5,000 fines per offense (up to $10,000 for synthetic THC products). In September 2025, the Maryland Court of Special Appeals upheld the mg caps and 21+ age requirement against an industry challenge, giving ATCC a clear runway for expanded statewide enforcement. The 2026 General Assembly did not loosen the caps: HB 1523 (Alcoholic Beverages Modernization Act), SB 820 (ATCC unauthorized consumable products enforcement), and HB 1519 (Cannabis Reform and Opportunity Act) all worked at the margins without touching §36-1102’s core mg limits. The 2025 session’s SB 215 removed a food-sales-tax exemption for cannabinoid beverages, ensuring that any compliant hemp beverage sold in Maryland now carries state sales tax. Medical cannabis patients access full-potency products through MCA-licensed dispensaries, and adult-use consumers 21+ have access to the state’s licensed cannabis market. Delivery of medical cannabis to qualifying patients through licensed dispensaries or registered delivery services was extended by SB 215 through June 30, 2026. For the federal cliff on November 12, 2026, Maryland is one of the states where Section 781 is largely a nonevent for hemp beverage brands: the state’s 2.5mg/package cap and MCA-licensure channel restriction already close the general-retail market. Section 781’s 0.4mg total-THC per-container federal ceiling is slightly tighter than Maryland’s per-package number, but the operative barrier remains the licensure requirement, which Section 781 does not disturb. The Maryland market post-cliff will look substantially like the Maryland market pre-cliff: any hemp beverage brand wanting distribution in the state needs to be a licensed Maryland cannabis operator, or accept that Maryland is closed.


Discover more from Cannabis.Wine

Subscribe to get the latest posts sent to your email.

This state summary has not yet been reviewed by counsel. Verify with your attorney before making commercial decisions.